Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · IEX Real-Time Price · USD
11.77
-0.04 (-0.34%)
Jul 22, 2024, 11:12 AM EDT - Market open
Cidara Therapeutics Employees
Cidara Therapeutics had 69 employees as of December 31, 2023. The number of employees decreased by 4 or -5.48% compared to the previous year.
Employees
69
Change (1Y)
-4
Growth (1Y)
-5.48%
Revenue / Employee
$672,145
Profits / Employee
-$528,493
Market Cap
54.06M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Inotiv | 2,055 |
Atara Biotherapeutics | 225 |
Barinthus Biotherapeutics | 130 |
Turnstone Biologics | 80 |
Aerovate Therapeutics | 51 |
LAVA Therapeutics | 37 |
Immix Biopharma | 17 |
vTv Therapeutics | 16 |
CDTX News
- 18 days ago - Cidara Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Cidara Therapeutics to Present Preclinical Data on CD388 at ASM Microbe 2024 Conference - GlobeNewsWire
- 2 months ago - Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Cidara Therapeutics Regains Compliance with Nasdaq Continued Listing Rules - GlobeNewsWire
- 2 months ago - CDTX INVESTOR NOTICE: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation - CDTX - PRNewsWire
- 3 months ago - Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024 - GlobeNewsWire
- 3 months ago - CDTX LOSS ALERT: ROSEN, A LEADING LAW FIRM, Encourages Cidara Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – CDTX - Business Wire
- 3 months ago - Cidara Therapeutics shares surge 30% after reacquiring flu treatment - Market Watch